Review article: The measurement of non-acid gastro-oesophageal reflux

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue SUPPL. 2, 2007, Pages 7-12

  Smout, A J P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; PROTON PUMP INHIBITOR;

ACID SECRETION; AMBULATORY MONITORING; CATHETER; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; COUGHING; DISEASE ASSOCIATION; ELECTRODE; ESOPHAGUS; ESOPHAGUS PH; FEASIBILITY STUDY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MORBIDITY; PH MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH FUNDOPLICATION; STOMACH JUICE; SYMPTOM;

BILIRUBIN; COUGH; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMANS; MONITORING, AMBULATORY;

EID: 36849084530     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03527.x     Document Type: Conference Paper

References (23)

1. Kahrilas PJ, Pandolfino JE. Review article: oesophageal pH monitoring - technologies, interpretation and correlationg with clinical outcomes. Aliment Pharmacol Ther 2005 22 (Suppl. 3 2 9.
2. Hirano I, Zhang Q, Pandolfino JE, Kahrilas PJ. Four-day bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005 3 : 1083 8.
3. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterology 1988 83 : 358 61.
4. Weusten BLAM, Roelofs JMM, Akkermans LMA, van Berge-Henegouwen GP, Smout AJPM. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal ph data. Gastroenterology 1994 107 : 1741 5.
5. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994 267 : G1050 7.
6. Marshall REK, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997 40 : 182 7.
7. Fass J, Silny J, Braun J, et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand J Gastroenterol 1994 29 : 693 702.
8. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004 53 : 1024 31.
9. Sifrim D, Holloway R, Silny J, et al. Acid, nonacid and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001 120 : 1588 98.
10. Zerbib F, Bruley des Varannes S, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005 22 : 1011 21.
11. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004 1037 : 1043.
12. Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Dis Sci 2006 38 : 226 32.
13. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006 101 : 1 8.
14. Bredenoord AJ, Weusten BLAM, Curvers WL, Timmer R, Smout AJPM. Determinants of perception of heartburn and regurgitation. Gut 2006 55 : 313 8.
15. Mainie T, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 55 : 1398 402.
16. Bredenoord AJ, Weusten BLAM, Timmer R, Conchillo JM, Smout AJPM. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006 101 : 453 9.
17. Vela MF, Tutuian RI, Sifrim D, Shay S, Zhang X, Castell DO. Comparison of pH-metry versus combined multichannel intraluminal impedance and pH (MII-pH) for symptom association studies in symptomatic acid suppressed GERD patients. Gastroenterology 2003 124 (Suppl. 1 A-542.
18. Bruley de Varannes S, Sacher-Huvelin S, Vavasseur F, et al. Rabeprzole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in primary care setting. World J Gastroenterol 2006 12 : 2569 73.
19. Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007 5 : 172 7.
20. Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2006 54 : 449 54.
21. Tutuian R, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006 130 : 386 91.
22. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006 93 : 1483 7.
23. Roman S, Bruley des Varannes S, Pouderoux P, et al. Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil 2006 11 : 978 86.